HealthProves
Symptom-centric view

Memory impairment

Substances reporting Memory impairment disproportionately — ranked by ROR.

PainDrug ineffectiveOff label useFatigueDyspnoeaAcute kidney injury
showing 193 of 193
Substance ↓ROR [95% CI]ReportsCategoryLabel
6.4 [4.9–8.4]54algemeennew
2.6 [2.2–2.9]241algemeennew
6.8 [5.6–8.2]104algemeennew
2.2 [1.6–3.0]36algemeennew
4.5 [3.9–5.1]202algemeennew
2.2 [1.8–2.6]130algemeennew
2.4 [2.3–2.5]3,776algemeennew
2.2 [1.7–2.9]53algemeennew
2.7 [2.2–3.2]101algemeennew
3.3 [2.8–3.8]142algemeennew
3.4 [2.5–4.5]46algemeennew
tretinoin
Retin-A · Atralin
5.4 [4.8–6.1]296injectablesnew
3.3 [2.9–3.6]323algemeennew
4.9 [4.6–5.2]1,511algemeennew
4.3 [4.1–4.4]2,636algemeennew
13.5 [11.0–16.5]104algemeennew
2.9 [2.6–3.2]303algemeennew
2.8 [2.5–3.1]356algemeennew
3.5 [3.1–3.8]393algemeennew
3.4 [3.2–3.6]889algemeennew
3.0 [2.8–3.3]578algemeennew
3.0 [2.8–3.2]807algemeennew
5.9 [5.6–6.1]1,657algemeennew
2.5 [2.0–3.3]61algemeennew
2.2 [1.9–2.4]365algemeennew
3.5 [2.6–4.7]47algemeennew
2.8 [2.6–3.0]1,185algemeennew
5.4 [4.8–6.1]305algemeennew
2.2 [2.1–2.3]1,683algemeennew
2.4 [1.5–3.7]20algemeennew
2.3 [1.8–3.1]53algemeennew
2.5 [2.0–3.2]67algemeennew
2.5 [2.0–3.0]101algemeennew
3.1 [3.0–3.3]2,316algemeennew
2.1 [2.0–2.3]953algemeennew
2.6 [2.2–2.9]234algemeennew
2.9 [2.3–3.7]64algemeennew
3.4 [3.1–3.8]403algemeennew
4.8 [4.4–5.2]578algemeennew
2.9 [2.8–3.0]3,529algemeennew
6.7 [5.7–7.9]160algemeennew
2.9 [2.5–3.4]189algemeennew
3.4 [3.3–3.5]5,652algemeennew
4.0 [3.7–4.4]494algemeennew
3.0 [2.0–4.5]25algemeennew
3.3 [3.1–3.5]1,103algemeennew
3.1 [2.8–3.4]408algemeennew
2.2 [2.1–2.4]582algemeennew
2.5 [2.1–3.1]95algemeennew
2.5 [2.1–3.0]121algemeennew
5.7 [5.2–6.2]470algemeennew
2.5 [2.3–2.8]536algemeennew
3.1 [2.9–3.2]1,772algemeennew
3.0 [2.9–3.2]1,774algemeennew
2.2 [2.1–2.3]1,336algemeennew
3.2 [2.8–3.7]178algemeennew
2.5 [2.3–2.7]597algemeennew
3.4 [3.2–3.7]705algemeennew
3.3 [3.1–3.6]694algemeennew
2.9 [2.7–3.0]1,126algemeennew
nicotinamide
Niacinamide
22.9 [20.3–25.7]316longevitynew
7.3 [7.2–7.5]7,943algemeennew
3.9 [2.8–5.4]38algemeennew
4.1 [3.8–4.4]833algemeennew
4.7 [4.4–5.0]1,124algemeennew
4.2 [3.6–4.9]161algemeennew
3.0 [2.4–3.8]82algemeennew
2.1 [2.0–2.3]811algemeennew
2.9 [2.2–3.7]62algemeennew
2.5 [1.8–3.3]44algemeennew
2.8 [2.4–3.1]249algemeennew
2.8 [2.4–3.1]249algemeennew
4.3 [3.3–5.5]60algemeennew
2.8 [2.5–3.1]351algemeennew
4.3 [3.3–5.5]60algemeennew
2.8 [2.5–3.1]278algemeennew
2.8 [2.4–3.1]278algemeennew
2.8 [2.5–3.1]351algemeennew
10.9 [9.9–12.1]387algemeennew
3.4 [2.5–4.5]46algemeennew
10.9 [9.9–12.1]387algemeennew
10.7 [9.6–11.9]387algemeennew
2.3 [2.0–2.5]306algemeennew
3.9 [3.4–4.6]165algemeennew
2.9 [2.6–3.2]466algemeennew
2.7 [2.5–2.9]727algemeennew
3.6 [3.2–3.9]480algemeennew
17.5 [15.1–20.3]195algemeennew
2.7 [2.6–2.9]1,031algemeennew
2.0 [1.9–2.1]1,714algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
2.6 [2.5–2.8]1,187algemeennew
2.6 [2.5–2.8]1,181algemeennew
3.2 [3.1–3.4]2,674algemeennew
2.6 [2.5–2.8]1,181algemeennew
3.0 [2.8–3.2]705algemeennew
3.8 [3.5–4.2]498algemeennew
4.2 [3.8–4.5]526algemeennew
2.9 [2.6–3.2]353algemeennew
6.9 [6.8–7.1]7,987algemeennew
2.1 [2.0–2.2]1,874algemeennew
2.3 [2.2–2.5]605algemeennew
10.9 [9.9–12.1]387algemeennew
2.8 [2.5–3.3]207algemeennew
2.7 [2.6–2.9]1,065algemeennew
2.7 [2.5–2.9]1,080algemeennew
2.6 [2.0–3.4]54algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
2.7 [2.2–3.3]93algemeennew
5.5 [5.3–5.7]2,967algemeennew
5.5 [5.3–5.7]2,984algemeennew
3.4 [2.5–4.6]46algemeennew
6.2 [5.6–6.8]439algemeennew
6.2 [5.6–6.8]439algemeennew
3.4 [3.0–3.7]362algemeennew
41.1 [36.6–46.2]361algemeennew
4.4 [3.6–5.4]90algemeennew
3.2 [3.0–3.4]1,116algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
2.2 [2.0–2.3]820algemeennew
4.5 [3.8–5.4]131algemeennew
2.3 [1.9–2.8]106algemeennew
3.0 [2.9–3.1]3,562algemeennew
3.0 [2.9–3.1]3,562algemeennew
3.2 [2.9–3.7]260algemeennew
3.2 [2.9–3.7]260algemeennew
3.3 [3.1–3.5]771algemeennew
2.4 [2.2–2.6]706algemeennew
7.6 [7.0–8.3]553algemeennew
2.7 [1.6–4.7]13algemeennew
2.6 [1.9–3.3]53algemeennew
7.5 [7.3–7.7]5,565algemeennew
2.8 [2.2–3.7]55algemeennew
2.7 [2.1–3.5]64algemeennew
3.4 [3.2–3.6]883algemeennew
3.2 [3.0–3.5]936algemeennew
3.5 [3.3–3.8]787algemeennew
3.2 [3.0–3.4]985algemeennew
2.1 [1.7–2.6]95algemeennew
2.3 [2.1–2.5]394algemeennew
2.3 [2.1–2.5]394algemeennew
5.4 [5.2–5.7]2,443algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
3.0 [2.9–3.1]2,998algemeennew
3.1 [2.4–3.9]65algemeennew
4.7 [4.2–5.4]244algemeennew
3.7 [2.9–4.7]70algemeennew
3.9 [3.2–4.8]102algemeennew
2.7 [2.5–2.9]802algemeennew
2.8 [2.6–3.0]938algemeennew
2.4 [2.3–2.6]1,040algemeennew
4.0 [3.8–4.2]1,582algemeennew
3.2 [2.8–3.8]173algemeennew
2.8 [2.2–3.4]86algemeennew
2.4 [2.1–2.8]168algemeennew
2.7 [2.6–2.9]1,908algemeennew
2.5 [2.4–2.6]2,402algemeennew
2.7 [2.3–3.2]164algemeennew
4.6 [3.9–5.5]132algemeennew
4.0 [3.5–4.5]215algemeennew
9.6 [8.9–10.3]711algemeennew
6.7 [5.8–7.7]186algemeennew
6.7 [5.8–7.7]186algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
10.9 [9.9–12.1]387algemeennew
3.6 [3.4–3.7]2,001algemeennew
15.5 [12.4–19.4]83algemeennew
7.0 [6.4–7.6]503algemeennew
4.6 [4.3–5.0]695algemeennew
5.5 [5.2–5.9]933algemeennew
2.2 [1.5–3.3]25algemeennew
3.3 [3.0–3.6]440algemeennew
3.2 [3.0–3.5]903algemeennew
3.0 [2.8–3.2]953algemeennew
3.6 [2.9–4.5]85algemeennew
2.3 [2.0–2.7]163algemeennew
4.8 [4.4–5.3]525algemeennew
3.3 [2.7–4.0]102algemeennew
3.6 [3.3–3.9]457algemeennew
4.9 [4.2–5.6]199algemeennew
3.9 [2.8–5.4]38algemeennew
15.5 [12.4–19.4]83algemeennew
15.5 [12.4–19.4]83algemeennew

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).